PRKN and neuroblastoma: USP33-knockdown increased the stability of parkin and its translocation to depolarized mitochondria, which enhanced mitophagy and protection to human neuroblastoma cells against apoptotic cell death induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.